DCOY.O (DCOY.O) News
Track canonical SquawkNews coverage tagged to DCOY.O, DCOY.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Decoy Therapeutics preclinical data support once-weekly intranasal dosing for DCOY-CoV
Decoy Therapeutics says preclinical pharmacokinetic results show a single weekly intranasal dose could sustain protective exposure across upper airways and lungs for about a week; clinical trials expected to begin in 202
EARNINGS | Sep 29, 2026, 11:37 AM UTC
M
Decoy Therapeutics says preclinical data support once-weekly intranasal dosing for DCOY-CoV
Decoy Therapeutics said a single intranasal dose maintained drug concentrations above designed therapeutic levels for up to seven days in nasal mucosa and lung tissue, with extended tissue retention supporting prophylaxi
EQUITY | Sep 29, 2026, 11:32 AM UTC